P ercutaneous transluminal coronary angioassessment of procedure efficacy, a functional evalplasty is an effective therapeutic procedure uation of the stenosis is mandatory. To avoid a in the management of properly selected subjective definition of clinical success on the basis patients with angina.1-3 For patient selection and of symptom classes, objective assessment of myocardial ischemia that results from a coronary steno-
Usefulness of High-Dose Dipyridamole
Echocardiography Test in Coronary Angioplasty Seventy-four consecutive patients with angina undergoing single-lesion percutaneous transluminal coronary angioplasty were evaluated with high-dose (up to 0.84 mg/kg during 10 minutes) dipyridamole echocardiography test (DET) before angioplasty and when possible, afterward. Angioplasty was clinically or angiographically successful in 63 patients and unsuccessful in 11. Before the procedure, 69 patients had a positive DET. Of these 69 patients, six with clinically unsuccessful angioplasty had a dipyridamole time (i.e., the time from the onset of dipyridamole infusion to development of asynergy) lower than the 63 patients with clinically successful angioplasty (4.2 ±2.9 vs. 7.0+2.9 minutes, mean± SD, p<0.01). In the five patients with angiographically unsuccessful angioplasty (residual stenosis diameter, >50%), coronary stenosis decreased from 89+10 to 69+22 (p=NS); DET was positive in all five before and in four of the five after the procedure (100% vs. 80%o, p=NS). In the 63 patients with angiographically successful angioplasty, coronary stenosis diameter was reduced from 85±9% to 30+10% (p<0.01). DET was positive in 58 patients before and in only 16 after the procedure (92% vs. 25%, p<0.01). In the 16 patients with positive DET, before and after angioplasty, dipyridamole time increased from 5.6±2.2 before to 7.3+±2.4 minutes immediately after the procedure (p<0.05). After an average follow-up time of 10.8±5.9 months, angina recurred in eight of 47 patients with negative DET after angioplasty and in 11 of 16 patients with positive DET (17% vs. 69%, p< 0.01). When angina symptoms recurred, a third DET was performed 1-3 days before repeat coronary angiography in 11 patients (3.6±2.7 months after the angioplasty). DET was positive in 10 of these patients, and all had coronary restenosis at angiography. DET was negative in the remaining patient, and this patient had no restenosis at angiography. These findings show that 1) before angioplasty, DET positivity with a very low dipyridamole time identifies a subset of patients at relatively higher risk of an unsuccessful procedure, 2) there is an excellent general correlation between the functional improvement assessed by DET and anatomic results of angioplasty, 3) DET positivity soon after successful angioplasty identifies a group at high risk for later recurrence of symptoms, and 4) when symptoms recur after angioplasty, DET positivity reliably identifies coronary restenosis. (Circulation 1989;80:807-815) electrocardiography,5 exercise radionuclide ventriculography,5 and thallium exercise scintigraphy.6 A drawback of exercise testing is that the attainment of diagnostically useful data requires a level of exercise to be achieved that increases myocardial oxygen demand substantially. Unfortunately, many patients are physically incapable of sufficiently vigorous exercise to provide diagnostically useful data.
Recently, dipyridamole echocardiography test (DET) was proposed as a method not dependent on exercise for the diagnosis of coronary artery disease. 7, 8 This tool seems particularly useful for the evaluation of angioplasty results because of its high accuracy, feasibility,9 and excellent short-term reproducibility. 10 Furthermore, its positivity is unaffected by the coronary tone variations that may so importantly modulate the effort tolerance during exercise stress testing."1 This aspect is particularly relevant in the angioplasty model because this therapy is more effective on the organic rather than on the vasospastic component of myocardial ischemia. 12, 13 The aim of this study was to assess the usefulness of DET in evaluating angioplasty results. We therefore performed DET immediately before singlelesion angioplasty in 74 consecutive patients. In 68 patients, DET was repeated immediately after the procedure. In a subset of 11 patients who had recurrent symptoms, a third DET was performed before repeat coronary angiography.
Methods Patients
Seventy-four patients (age, 52±6 years; 65 men, nine women) were enrolled in this study. All patients met the following inclusion criteria: 1) typical anginal symptoms before angioplasty, with stressinduced myocardial ischemia documented by exercise electrocardiographic stress test or DET and 2) acceptable acoustic window in resting conditions. Sixty-two patients had single-vessel coronary artery disease, and 12 had double-vessel disease. Twenty-seven patients had a previous myocardial infarction and a regional infarct-related asynergy on the resting echocardiogram.
In all patients, DET was performed before (range, 1-5 days) angioplasty. In 68 patients, DET was also performed after (range, 1-3 days) angioplasty. Fiftyone patients were tested (before and after angioplasty) after discontinuation of antianginal therapy; 17 patients were tested (before and after angioplasty) under the identical antianginal therapy, that is, with calcium antagonists or nitrates.
In a subset of 11 other patients, DET was repeated a third time, at a variable interval from the procedure, for recurrence of angina.
Coronary Stenosis Analysis
Selective right and left coronary angiography was performed by the Judkins or Sones technique. Each stenoses were expressed as the percent diameter reduction compared with the nearest normal arterial segment in the view where it appeared the most severe. The angiograms were reviewed by an angiographer unaware of the clinical and DET data. After visual inspection of the coronary arteries in all views, the frame in which the most severe lesion appeared was selected and analyzed by means of a calibrated eyepiece that provided magnification and contained a Vernier millimeter scale. '4 In the case of double-vessel disease, angioplasty was performed on the "ischemia-producing" vessel identified by the following criteria: 1) in the absence of previous myocardial infarction, the more stenotic coronary artery was considered the ischemia-producing artery, 2) in presence of a previous myocardial infarction with an occluded vessel feeding an akynetic region, the other vessel was considered the ischemia-producing artery, and 3) the vessel feeding the territory showing transient dyssynergy during DET was considered the ischemia-producing vessel. In all cases in which positive DET was obtained before angioplasty, the above angiographic criteria were concordant with the echocardiographic localization of ischemic territory.
Dipyridamole Echocardiography Test
Two-dimensional echocardiographic monitoring was performed in combination with dipyridamole infusion8: 0.56 mg/kg during 4 minutes, no dose for 4 minutes, and then 0.28 mg/kg during 2 minutes. The cumulative dose was therefore 0.84 mg/kg during 10 minutes. During each minute of the procedure, blood pressure and the electrocardiogram were recorded. Two-dimensional echocardiograms were continuously monitored and intermittently recorded during and up to 10 minutes after dipyridamole administration. A commercially available wide-angle phased-array imaging system (Model 77020, with 2.5and 3.5-MHz transducers, Hewlett Packard, Andover, Massachusetts) was used.
All patients received intravenous aminophylline (50-240 mg) at the end of the test.
Regional Wall Motion Analysis
In 115 of the 153 studies (75%), a two-dimensional echocardiographic analysis was performed, after off-line digitization, by an array processor-based computer for medical image processing (Mipron, Kontron, FRG).
Regional wall motion analysis before and after dipyridamole administration was performed either in the parasternal short-axis view or, more frequently, in the apical view. The end-diastolic and end-systolic frames were identified by bidimensional frame-by-frame review, and the endocardial edge was traced. The left ventricle was divided into 24 segments. For each segment, a percent area change was calculated with the use of a floating vessel was filmed in multiple views. Coronary center-of-mass reference system. A 
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cardiac cycle was analyzed in the same projection in resting conditions and at peak dipyridamole. A test was considered positive if at peak dipyridamole administration the percent area change decreased by more than 20% in more than two adjacent segments compared with resting state. An example of a positive test is shown in Figure 1 .
In 38 studiesY the images were considered adequate for qualitative analysis but not for quantitative assessment. Wall motion was assessed in a qualitative manner as previously reported7 and graded as hyperkinetic, normal, hypokinetic, akinetic, or dyskinetic. Positivity of the test was linked to detection of a transient regional change of contraction of one grade or more. In these studies, there were two split decisions (requiring a third observer).
For the positive studies, we also recorded the "dipyridamole time," that is, the time from the onset of dipyridamole infusion to development of frank asynergy. 
Statistical Analysis
Continuous data are expressed as the mean-+-SD. Nonparametric differences were examined using a X2test. Parametric differences were examined using the Student's t test.
Results
Angiographic and echocardiographic data obtained before and after angioplasty of the 74 study patients are displayed in Table 1 .
Hemodynamic Findings During Dipytidamole Echocardiography Test
No patient had severe hypotension (blood pressure fall >40 mm Hg) during DET. In the 142 studies before and immediately after angioplasty, similar hemodynamic findings were found in patients during negative DET (n=57) and positive DET (n=85). In particular, the rate-pressure product (mm Hg X beats/min X 1/100) increased from 106 :t 15 RCA  LAD  LAD  LAD  RCA  RCA  RCA  RCA  LAD  RCA  RCA  LAD  RCA  LCx  LAD  LCx  LAD  RCA  RCA  LCx  RCA  LAD  LAD  LAD  RCA  LAD  LAD  LCx  RCA  LAD  RCA  LAD  LCx  LAD  RCA  LAD  LAD  RCA  RCA  LAD  LAD  LAD  RCA  LAD  LAD  LAD  LAD  RCA  LAD  LCx   Patient  1  2  3   4   5   6  7  8  9  10   11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38   39   40  41  42  43  44  45  46  47  48  49  50 (resting conditions) to 123±19 (peak dipyridamole, p<0.01 vs. basal conditions) in negative DET and increased from 104±13 to 140±24 (p<0.01) in positive DET. Intergroup differences were not significant both during resting conditions and at peak dipyridamole effect.
Quantitative Echocardiographic Data
Results before angioplasty. In the 62 patients with single-vessel disease, quantitative analysis was performed in 47 patients. DET was positive in 44 of these patients. The number of segments per patient showing an abnormal function during DET was 6.2±2.8.
In the 12 patients with double-vessel disease, a quantitative analysis was performed in nine patients. The number of segments per patient showing an abnormal function during DET was 6.7±2.8.
Results after angioplasty. Of the 68 patients who underwent repeat DET after angioplasty, quantitative analysis was performed in 56. DET was positive in 16 patients. The number of segments per patient showing an abnormal function during DET was 4.7±1.3. In the 11 patients with a third DET, quantitative analysis was performed in nine. DET was positive in eight patients. The number of segments per patient showing an abnormal function during DET was 5.2+1.7.
Results of Dipyridamole Echocardiography Test Before Angioplasty
Before angioplasty, 69 patients had a positive DET, and five had a negative DET. In these five patients, revascularization was recommended on the basis of positive exercise stress testing. Of the 69 patients with positive DET, 57 had singleand 12 had double-vessel disease. In these last 12 patients, angioplasty was selectively performed on the ischemia-producing coronary artery, which was identified by the concordant criteria of dyssynergic territory during DET and from angiographic findings. For instance, one patient (No. 7 in Table 2 ) with no previous myocardial infarction, greater than 90% stenosis of the right coronary artery, and 76% stenosis of the left anterior descending artery had a posterior asynergy during DET. Angioplasty was performed on the right coronary artery lesion, and anginal symptoms disappeared after angioplasty. Another patient (No. 1 in Table 2 ) with a previous myocardial infarction and akinetic inferior left ventricular wall had two-vessel disease, 70% stenosis of the left anterior descending artery, and 100% stenosis of the right coronary artery. In this patient, the anterior region became asynergic during DET. A selective angioplasty was performed on the left anterior descending coronary artery, and anginal symptoms disappeared after angioplasty. Correlation Between Results Immediately After Angioplasty and Results of Dipyridamole Echocardiography Test Before Angioplasty There were 63 successful procedures (diameter reduction of >20% and residual stenosis <50%) and 11 unsuccessful procedures: two patients died, two had myocardial infarction, two underwent emergency coronary revascularization, and five had angiographically unsuccessful angioplasty (diameter reduction <20% or residual stenosis >50%).
The six patients with clinically unsuccessful angioplasty had a positive DET before angioplasty and a lower dipyridamole time compared with the 63 patients with successful angioplasty and positive DET before angioplasty (4.2±+ 1.9 vs. 7.0±2.9 minutes, p<0.01). Also, the number of asynergic segments was higher in patients with clinically unsuccessful angioplasty (8.0 ± 3.3 vs. 6.0 ± 2.9, p < 0. 05).
With a dipyridamole time less than 4 minutes used as an arbitrary cut-off point, the diagnostic accuracy of this abnormally low dipyridamole time to predict unsuccessful angioplasty was 77%; the sensitivity was 67%, the specificity was 22%, and the predictive value of a positive DET was 21% and Angiographically complex coronary lesions, that is, long (>5 mm), eccentric, irregular plaques often with calcifications, occurred in 20 patients. Six of these patients had clinically unsuccessful angioplasty, and the remaining 14 had successful angioplasty.
Immediate Effect ofAngioplasty on Dipyridamole Echocardiography Test
In the five patients with angiographically unsuccessful angioplasty, coronary stenosis decreased from 89+10% to 69+±22% (p=NS). DET was positive in all five patients before and in four of the five after the procedure (100% vs. 80%, p=NS).
In the 63 patients with angiographically successful angioplasty, there was an immediate decrease in coronary obstruction from 85±+9% to 30+10% (p<0.01). In these patients, DET was positive in 58 patients before angioplasty and in 16 after the procedure (92% vs. 25%, p<0.01). Thirteen of these 16 had single-vessel disease, and three had multivessel disease. The positive DET after angioplasty was in the area of the vessel that was dilated in all 13 patients with single-vessel disease and in one of the three patients with multivessel disease; the remaining two patients showed the asynergy in the area fed by the nondilated vessel (Table 2) . High-grade residual stenoses with negative tests were associated with prior infarction in that region.
In the 16 patients with positive DET, dipyridamole time increased from 5.6±2.2 to 7.3±2.4 minutes immediately after angioplasty (p<0.05) ( Figure 2 ). In these patients, the number of asynergic segments, quantitatively estimated in the same projection at peak dipyridamole both before and after the procedure, decreased from 6.8±2.4 to 4.7±1.3 (p<0.01). The electrocardiographic pattern associated with the dyssynergy before angioplasty was ST segment elevation in three patients, ST segment depression in 11, and no significant changes in two. In these 16 patients, the DET after angioplasty showed ST segment elevation in two, ST segment depression in 11, and no electrocardiographic changes in four (Figure 2 ).
Follow-up Data
The mean follow-up time was 10.8±5.9 months (range, 2 to 22 months). The duration of the followup was similar in the two groups of patients with negative and positive DET immediately after angioplasty (11.0±5.7 vs. 10. 1±5.3 months).
Anginal symptoms recurred in 19 patients: in eight of the 47 patients with negative DET after angioplasty and in 11 of the 16 patients with positive DET (17% vs. 69%,p<0.01) after the procedure.
When anginal symptoms recurred, a third DET was performed 1-3 days before repeat coronary angiography in 10 patients (3.6±2.7 months after the first angioplasty). DET was positive in 10 of a negative DET was 96%. patients, and all had coronary restenosis at angiog- raphy. The remaining patient had a negative DET and no restenosis at coronary angiography.
Discussion
DET has been shown to be a safe, feasible, and accurate non-exercise-dependent provocative test with very high specificity and acceptable sensitivity for detection of angiographically assessed coronary artery disease. 8, 15"6 Clinical 
Usefulness of Dipyridamole Echocardiography Test in Angioplasty
Before angioplasty, DET allows the clinician to anatomically localize the site and extent of myocardial ischemia and to document in an objective manner the physiologic consequences of a coronary stenosis. 15 Furthermore, a very low dipyridamole time, with extensive dyssynergy at peak dipyridamole, identifies a group at a relatively higher risk of unsuccessful or complicated angioplasty. This finding can be explained by the results of a previous study that showed that the earlier the echocardiographic positivity during dipyridamole infusion, the lower the ischemic ceiling on exercise stress testing.17 It is therefore conceivable that the coronary reserve in these patients is very low, and the recovery after a complete balloon occlusion, linked to reactive hyperemia, may be slow and incomplete, therefore increasing the risk of ischemic damage.
DET appears also suitable for the immediate assessment of angioplasty efficacy. The possible physiologic benefit determined by the angioplasty on the regional coronary reserve seems the most likely explanation of the improvement in DET results. A persistently positive DET after angioplasty has an unfavorable prognostic implication, placing the patient in a subset at high risk for recurrence of symptoms. This finding appears to be consistent with the strong prognostic power shown by DET in a population of patients with angina. 18 In the long-term follow-up of a patient treated with angioplasty, DET can also be valuable as a tool to detect restenosis. This is particularly true in patients complaining of typical or atypical angina, which may recur after angioplasty in the absence of a significant restenosis, possibly because of vasospastic phenomena.13
Dipyridamole Echocardiographic Test Compared With Angiographic Results
DET does not offer a dichotomic answer (positivity vs. negativity) but rather a graded positive response that can be usefully stratified along three coordinates: transmural extension of ischemia (on the basis of the associated electrocardiographic pattern), spatial circumferential extent, and timing of the asynergy during dipyridamole stress. 15"19 In patients in whom the test is still positive after angioplasty, these three coordinates help to detect and quantify less dramatic improvements in the regional performance. '19 We found that there is, with few exceptions, an excellent correlation between DET response and anatomic results. The limited or even the total lack of improvement in DET response after an angiographically successful angioplasty can have several explanations. The residual stenosis can be anatomically "insignificant" and still hemodynamically important because there is a poor correlation between percent lumen reduction and regional flow reserve, particularly very early after angioplasty.4 Alternatively, there may be an early restenosis of a vessel in the very first few days after angioplasty that could be a nonsignificant stenosis at the time of follow-up angiography after angioplasty.20 Consistent with this explanation is the finding that in all 10 patients with recurrent angina and positive DET, repeat angiography showed restenosis of the previously treated vessel.
Dipyridamole Echocardiography Test in Multivessel Disease
The presence of multivessel disease can affect the DET study in several ways. Obviously, as happens with several diagnostic tests, the sensitivity of DET is higher in multivessel than in single-vessel disease.16 In the evaluation of the patient before angioplasty, DET may usefully integrate the angiographic criteria for identifying the ischemiaproducing vessel in multivessel disease. In the evaluation after angioplasty, a positive DET can be of help in separating patients with persistent positivity in the territory of the dilated coronary artery or with positivity in the territory fed by the lessdiseased coronary vessel.
In the first case, the angioplasty was ineffective, or stenosis recurred in the dilated vessel. In the second case, both stenosed vessels had a significant reduction in regional flow reserve before angioplasty, and the DET, which is stopped at the appearance of a regional asynergy, localized only the more-diseased vessel.
The correction of the stenosis in the most-diseased artery can unmask as "functionally dominant" the artery that originally was less stenosed. It is an educated guess that one needs to be cautious in indicating a selective coronary angioplasty in the ischemia-producing vessel when the asynergy is elicited at a very low dipyridamole time in a patient with multivessel disease. For such a case, there would be a high chance that even with the correction of the 4"culprit," stenosis residual ischemia might be evoked in the territory of the less-diseased artery.
Limitations of Dipyridamole Echocardiography Test in Coronary Angioplasty
Some of the difficulties concerning the clinical applicability of the data obtained in this investigation should be mentioned. Obviously, the DET requires an acceptable acoustic window in resting conditions and specialized personnel for the performance and interpretation of the test. Furthermore, the DET cannot be effectively used to assess the results of angioplasty in those patients in whom DET was negative before the procedure (7% of patients in this study). Finally, the occasional discordance between DET and angiographic findings should be evaluated in comparison with a measure of the physiologic state of coronary flow reserve to have a clearer idea of the clinical meaning of DET results. Therefore, we believe that more data are needed to clarify the full potential of DET in the management of the patient undergoing angioplasty.
We conclude that DET can play a role in the management of patients undergoing angioplasty. Before angioplasty, DET allows the localization of the site and extent of myocardial ischemia in a manner independent from coronary tone modula-dyssynergy, identifies a subset of patients at a relatively higher risk of an unsuccessful procedure. Moreover, DET usefully integrates the angiographic criteria for identifying the ischemiaproducing vessel in multivessel disease. After angioplasty, DET can be useful because 1) there is an excellent correlation between the functional improvement in dipyridamole stress testing and anatomic results of angioplasty, 2) DET positivity soon after angiographically successful angioplasty identifies patients at high risk for recurrence of symptoms, and 3) when symptoms recur after angioplasty, DET reliably identifies coronary restenosis.
